FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013215737> ?p ?o ?g. }

• W3013215737 endingPage "1146" @default.
• W3013215737 startingPage "1137" @default.
• W3013215737 abstract "Background and aims The increased risk of cardiovascular disease under hypercholesterolemia is due to associations between oxidized low-density lipoprotein (ox-LDL) and lipoprotein-associated phospholipase A2 (Lp-PLA2) and between ox-LDL and coagulant profiles. We investigated the impact of different ox-LDL levels on coagulation time and plasma metabolomes in subjects with borderline hypercholesterolemia. Methods and results One hundred thirty-one subjects with borderline hypercholesterolemia (serum cholesterol ≥200 mg/dL) were divided into low ox-LDL (n = 66) and high ox-LDL (n = 65) groups. After adjusting for confounding factors, the high ox-LDL group exhibited a significantly decreased activated partial thromboplastin time (aPTT) and prothrombin time (PT) and increased Lp-PLA2 activity. Compared to the low ox-LDL group, the high ox-LDL group exhibited significantly increased intensities of 17 lysophosphatidylcholines (lysoPCs) and 7 lysophosphatidylethanolamines (lysoPEs). Ox-LDL was inversely correlated with aPTT and PT and positively correlated with Lp-PLA2 activity. Positive correlations were also found among ox-LDL, Lp-PLA2 activity, lysoPCs, and lysoPEs. LysoPCs and lysoPEs were inversely correlated with PT and aPTT. The identified plasma metabolites, including amino acids, fatty acid amides, acylcarnitines, and lysophospholipids, were significantly upregulated in the high ox-LDL group. Conclusion High ox-LDL levels may be involved in the development of a procoagulant state in subjects with borderline hypercholesterolemia by increasing Lp-PLA2 activity and lysoPC and lysoPE levels." @default.
• W3013215737 created "2020-04-03" @default.
• W3013215737 creator A5010112690 @default.
• W3013215737 creator A5061986607 @default.
• W3013215737 creator A5067898316 @default.
• W3013215737 creator A5090977989 @default.
• W3013215737 date "2020-06-01" @default.
• W3013215737 modified "2023-10-14" @default.
• W3013215737 title "Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA2 activity in borderline hypercholesterolemia" @default.
• W3013215737 cites W1743217927 @default.
• W3013215737 cites W1968642527 @default.
• W3013215737 cites W1976938123 @default.
• W3013215737 cites W1981446927 @default.
• W3013215737 cites W1998166048 @default.
• W3013215737 cites W2001047636 @default.
• W3013215737 cites W2002442315 @default.
• W3013215737 cites W2004680931 @default.
• W3013215737 cites W2007385256 @default.
• W3013215737 cites W2018105466 @default.
• W3013215737 cites W2021679109 @default.
• W3013215737 cites W2031464251 @default.
• W3013215737 cites W2032156196 @default.
• W3013215737 cites W2039173759 @default.
• W3013215737 cites W2040783773 @default.
• W3013215737 cites W2042127233 @default.
• W3013215737 cites W2043140624 @default.
• W3013215737 cites W2051906873 @default.
• W3013215737 cites W2056296858 @default.
• W3013215737 cites W2070346524 @default.
• W3013215737 cites W2084008596 @default.
• W3013215737 cites W2089622153 @default.
• W3013215737 cites W2089959473 @default.
• W3013215737 cites W2090080882 @default.
• W3013215737 cites W2101207877 @default.
• W3013215737 cites W2109182499 @default.
• W3013215737 cites W2114312858 @default.
• W3013215737 cites W2124979797 @default.
• W3013215737 cites W2127850831 @default.
• W3013215737 cites W2133607184 @default.
• W3013215737 cites W2143064104 @default.
• W3013215737 cites W2145598472 @default.
• W3013215737 cites W2157054509 @default.
• W3013215737 cites W2173701799 @default.
• W3013215737 cites W2277827356 @default.
• W3013215737 cites W2294815055 @default.
• W3013215737 cites W2327172638 @default.
• W3013215737 cites W2329065225 @default.
• W3013215737 cites W2331402538 @default.
• W3013215737 cites W2441093478 @default.
• W3013215737 cites W2460300122 @default.
• W3013215737 cites W2919002166 @default.
• W3013215737 cites W4211051145 @default.
• W3013215737 cites W4230870013 @default.
• W3013215737 cites W4242963513 @default.
• W3013215737 doi "https://doi.org/10.1016/j.numecd.2020.03.015" @default.
• W3013215737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32456947" @default.
• W3013215737 hasPublicationYear "2020" @default.
• W3013215737 type Work @default.
• W3013215737 sameAs 3013215737 @default.
• W3013215737 citedByCount "12" @default.
• W3013215737 countsByYear W30132157372021 @default.
• W3013215737 countsByYear W30132157372022 @default.
• W3013215737 countsByYear W30132157372023 @default.
• W3013215737 crossrefType "journal-article" @default.
• W3013215737 hasAuthorship W3013215737A5010112690 @default.
• W3013215737 hasAuthorship W3013215737A5061986607 @default.
• W3013215737 hasAuthorship W3013215737A5067898316 @default.
• W3013215737 hasAuthorship W3013215737A5090977989 @default.
• W3013215737 hasConcept C126322002 @default.
• W3013215737 hasConcept C134018914 @default.
• W3013215737 hasConcept C181199279 @default.
• W3013215737 hasConcept C185592680 @default.
• W3013215737 hasConcept C2776330855 @default.
• W3013215737 hasConcept C2776551241 @default.
• W3013215737 hasConcept C2777034527 @default.
• W3013215737 hasConcept C2778163477 @default.
• W3013215737 hasConcept C2778261982 @default.
• W3013215737 hasConcept C2778382381 @default.
• W3013215737 hasConcept C2778596009 @default.
• W3013215737 hasConcept C2778918659 @default.
• W3013215737 hasConcept C2779620165 @default.
• W3013215737 hasConcept C2780072125 @default.
• W3013215737 hasConcept C2781112429 @default.
• W3013215737 hasConcept C41625074 @default.
• W3013215737 hasConcept C55493867 @default.
• W3013215737 hasConcept C71924100 @default.
• W3013215737 hasConceptScore W3013215737C126322002 @default.
• W3013215737 hasConceptScore W3013215737C134018914 @default.
• W3013215737 hasConceptScore W3013215737C181199279 @default.
• W3013215737 hasConceptScore W3013215737C185592680 @default.
• W3013215737 hasConceptScore W3013215737C2776330855 @default.
• W3013215737 hasConceptScore W3013215737C2776551241 @default.
• W3013215737 hasConceptScore W3013215737C2777034527 @default.
• W3013215737 hasConceptScore W3013215737C2778163477 @default.
• W3013215737 hasConceptScore W3013215737C2778261982 @default.
• W3013215737 hasConceptScore W3013215737C2778382381 @default.
• W3013215737 hasConceptScore W3013215737C2778596009 @default.
• W3013215737 hasConceptScore W3013215737C2778918659 @default.

• next